Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
After-Hours: 20:00
Ambrx Biopharma Profit Margin (Quarterly): -43.38K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -43.38K% |
| June 30, 2023 | -1.59K% |
| March 31, 2023 | -63.76K% |
| December 31, 2022 | -378.1% |
| Date | Value |
|---|---|
| September 30, 2022 | -974.8% |
| June 30, 2022 | -2.22K% |
| March 31, 2022 | -1.40K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-63.76K%
Minimum
Mar 2023
-378.1%
Maximum
Dec 2022
-16.24K%
Average
-1.59K%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 15.22% |
| Axonics Inc | -20.91% |
| Harpoon Therapeutics Inc (DELISTED) | -40.51% |
| Merck & Co Inc | 30.19% |
| RayzeBio inc (DELISTED) | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.85% |
| Return on Assets | -29.51% |
| Return on Invested Capital | -33.81% |
| Operating Margin (Quarterly) | -48.35K% |
| Return on Net Operating Assets | -153.7% |